Abstract P6-01-41: Influence of HER2 expression status in the distribution of recurrence score from the OncotypeDx assay among women with early-stage estrogen-receptor-positive/HER2-negative breast cancer
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Cancer Research
Conference Name
2022 San Antonio Breast Cancer Symposium
Conference Date
2022-12-06 - 2022-12-10
First Page
P6-01-41
DOI
10.1158/1538-7445.SABCS22-P6-01-41
Volume
83
Issue
5_Supplement
Publication Date
3-1-2023
Recommended Citation
Shah, A., Budhathoki, P., Gaire, S., Joshi, U., & Yadav, S. (2023). Abstract P6-01-41: Influence of HER2 expression status in the distribution of recurrence score from the OncotypeDx assay among women with early-stage estrogen-receptor-positive/HER2-negative breast cancer. Cancer Research, 83 (5_Supplement), P6-01-41. https://doi.org/10.1158/1538-7445.SABCS22-P6-01-41
COinS